{
  "question": "True regarding acetazolamide is ?",
  "is_multi_choice": true,
  "correct_answer": "opb",
  "options": {
    "opa": "Irreversible inhibitor of carbonic anhydrase",
    "opb": "Structural resemblance to sulfonamides",
    "opc": "It decreases Na, K, Glucose excretion",
    "opd": "It causes metabolic alkalosis"
  },
  "topic_name": "Pharmacology",
  "context": null,
  "initial_causal_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [
      [
        "Acetazolamide",
        "Metabolic alkalosis"
      ]
    ],
    "relationships": [
      [
        "TREATS"
      ]
    ],
    "paths": [
      "(Acetazolamide)-TREATS->(Metabolic alkalosis)"
    ]
  },
  "causal_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [],
    "relationships": [],
    "paths": []
  },
  "knowledge_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [],
    "relationships": [],
    "paths": []
  },
  "enhanced_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [],
    "relationships": [],
    "paths": []
  },
  "reasoning_chain": [],
  "enhanced_information": "",
  "analysis": "Acetazolamide is a reversible inhibitor of carbonic anhydrase, not irreversible. It does have structural resemblance to sulfonamides. It primarily increases the excretion of bicarbonate, leading to metabolic acidosis rather than alkalosis. It does not decrease Na, K, or glucose excretion significantly. Therefore, the correct statement is that it has structural resemblance to sulfonamides.",
  "answer": "opb",
  "confidence": 90.0,
  "chain_coverage": {
    "success_counts": [],
    "coverage_rates": [],
    "total_successes": 0
  }
}